Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences

Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences / Mazzoni F.; Petreni P.; Perna M.; Scotti V.; Bongiolatti S.; Livi L.; Di Costanzo F.; Voltolini L.. - In: TUMORI. - ISSN 0300-8916. - ELETTRONICO. - 104:(2018), pp. NP5-NP9-NP9. [10.1177/0300891618775204]

Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences

Voltolini L.
2018

Abstract

Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences
2018
104
NP5-NP9
NP9
Goal 3: Good health and well-being for people
Mazzoni F.; Petreni P.; Perna M.; Scotti V.; Bongiolatti S.; Livi L.; Di Costanzo F.; Voltolini L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1177391
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact